1. Home
  2. TIL vs PESI Comparison

TIL vs PESI Comparison

Compare TIL & PESI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIL
  • PESI
  • Stock Information
  • Founded
  • TIL 2018
  • PESI 1990
  • Country
  • TIL United States
  • PESI United States
  • Employees
  • TIL N/A
  • PESI N/A
  • Industry
  • TIL Biotechnology: Pharmaceutical Preparations
  • PESI Environmental Services
  • Sector
  • TIL Health Care
  • PESI Industrials
  • Exchange
  • TIL Nasdaq
  • PESI Nasdaq
  • Market Cap
  • TIL 177.1M
  • PESI 205.4M
  • IPO Year
  • TIL 2021
  • PESI 1992
  • Fundamental
  • Price
  • TIL $21.03
  • PESI $9.56
  • Analyst Decision
  • TIL Buy
  • PESI
  • Analyst Count
  • TIL 6
  • PESI 0
  • Target Price
  • TIL $120.50
  • PESI N/A
  • AVG Volume (30 Days)
  • TIL 150.1K
  • PESI 312.2K
  • Earning Date
  • TIL 11-12-2025
  • PESI 11-12-2025
  • Dividend Yield
  • TIL N/A
  • PESI N/A
  • EPS Growth
  • TIL N/A
  • PESI N/A
  • EPS
  • TIL N/A
  • PESI N/A
  • Revenue
  • TIL N/A
  • PESI $60,019,000.00
  • Revenue This Year
  • TIL N/A
  • PESI $8.35
  • Revenue Next Year
  • TIL N/A
  • PESI $82.81
  • P/E Ratio
  • TIL N/A
  • PESI N/A
  • Revenue Growth
  • TIL N/A
  • PESI N/A
  • 52 Week Low
  • TIL $10.80
  • PESI $6.25
  • 52 Week High
  • TIL $73.69
  • PESI $16.25
  • Technical
  • Relative Strength Index (RSI)
  • TIL 37.54
  • PESI 42.82
  • Support Level
  • TIL $20.11
  • PESI $8.14
  • Resistance Level
  • TIL $25.89
  • PESI $12.32
  • Average True Range (ATR)
  • TIL 2.57
  • PESI 0.87
  • MACD
  • TIL -0.69
  • PESI -0.27
  • Stochastic Oscillator
  • TIL 6.70
  • PESI 35.81

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About PESI Perma-Fix Environmental Services Inc.

Perma-Fix Environmental Services Inc is a provider of both nuclear services and the management of nuclear and mixed waste. The company operates through two segments: The treatment segment offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.

Share on Social Networks: